Loratadine and Harvoni drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loratadine (loratadine) and Harvoni (ledipasvir; sofosbuvir). Common drug interactions include rhabdomyolysis among females and alcohol withdrawal syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Loratadine and Harvoni. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

What is Harvoni?

Harvoni has active ingredients of ledipasvir; sofosbuvir. eHealthMe is studying from 19,858 Harvoni users. Check the latest studies of Harvoni.



On Jul, 10, 2026

38 people who take Loratadine and Harvoni together, and have interactions are studied.

Loratadine and Harvoni drug interactions.

What are the common drug interactions of Loratadine and Harvoni, by gender? *:

female:

  1. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Swelling
  5. Urinary tract infection
  6. Vision blurred
  7. Headache (pain in head)
  8. Chronic kidney disease
  9. Pyrexia (fever)
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Alcohol withdrawal syndrome
  2. Anaemia (lack of blood)
  3. Pain
  4. Depression
  5. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  6. Hypoxia (low oxygen in tissues)
  7. Mobility decreased (ability to move is reduced)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Substance abuse
  10. Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Loratadine and Harvoni, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Lacrimation increased
  2. Papilloedema (optic disc swelling)
  3. Substance abuse
  4. Vision blurred
  5. Alcohol withdrawal syndrome
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Asthenia (weakness)
  8. Burning sensation
  9. Eye pruritus (eye itching)
  10. Headache (pain in head)

40-49:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Back pain
  5. Chest pain
  6. Chills (felling of cold)
  7. Chronic kidney disease
  8. Drug ineffective
  9. Dysstasia (difficulty in standing)
  10. Emotional distress

50-59:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Hepatitis c
  4. Alopecia (absence of hair from areas of the body)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Bacterial infection
  8. Blood creatinine increased
  9. Cellulitis (infection under the skin)
  10. Chronic kidney disease

60+:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Postictal state
  6. Abdominal pain
  7. Alanine aminotransferase increased
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Aspartate aminotransferase increased
  10. Death

What are the existing conditions these people have? *

  1. Hepatitis C: 25 people, 65.79%
  2. Hiv Infection: 5 people, 13.16%
  3. Pain: 4 people, 10.53%
  4. Hypersensitivity: 3 people, 7.89%
  5. Diabetes: 3 people, 7.89%
  6. Infection: 2 people, 5.26%
  7. High Blood Pressure: 2 people, 5.26%
  8. Gout (uric acid crystals building up in the body): 2 people, 5.26%
  9. Constipation: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and Harvoni?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loratadine and Harvoni:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loratadine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Harvoni:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loratadine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Harvoni and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and ledipasvir; sofosbuvir (the active ingredients of Loratadine and Harvoni, respectively), and Loratadine and Harvoni (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: